BRILINTA (Ticagrelor) — NDC 0186-0776 by AstraZeneca Pharmaceuticals LP
BRILINTA (Ticagrelor) — NDC 0186-0776 by AstraZeneca Pharmaceuticals LP is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: BRILINTA; Generic name: Ticagrelor; Product NDC: 0186-0776.
| Brand name | BRILINTA |
|---|---|
| Generic name | Ticagrelor |
| Product NDC | 0186-0776 |
| Labeler | AstraZeneca Pharmaceuticals LP |
| Dosage form | TABLET |
| Route | ORAL |
| Active ingredients | TICAGRELOR 60 mg/1 |
| Pharmacologic class | Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA] |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →